Solana Company HSDT FINANCIAL
Company Overview
Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.
Why Investors Should Care
Trades at a P/E of 0.0, below the sector median of 12.9.
Carries low leverage with a debt-to-equity ratio of 0.00.
Recent Developments
- Dec 2025 Revenue of $548.00K (+5.4% YoY); net profit $-40.89M.
- 5-Year Trend Long-term compounding — revenue CAGR 2.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.97% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -62.88% |
| 6 Months: | -3.45% |
| 3 Months: | +62.32% |
| 1 Month: | +32.54% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)59.21 · Neutral
P/E of 0.01 is below the sector median of 12.89 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 90.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HSDT Solana Company FINANCIAL | 2.24 | 0.01 | $135.43M | 0.00% | -81.03% | - | 1.97% | - |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2014 | Sep 2014 | Dec 2014 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 677.00K | 518.00K | 150.00K | 207.00K | 133.00K | 131.00K | 84.00K | 63.00K | 102.00K | 183.00K | 119.00K | 195.00K | 106.00K | 244.00K | 132.00K | 124.00K | 171.00K | 40.00K | 38.00K | 33.00K | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 441.00K | 306.00K | 61.00K | 106.00K | 69.00K | 109.00K | 69.00K | 4.00K | 23.00K | 66.00K | 31.00K | 95.00K | -11.00K | 72.00K | -44.00K | 12.00K | 64.00K | -136.00K | -72.00K | -53.00K | 594.00K | 3.44M |
| Operating Income | - | -1.38M | -2.76M | -3.09M | -2.99M | -725.67K | -2.84M | -2.92M | -2.10M | -3.39M | -5.03M | -5.98M | -5.97M | -4.72M | -11.81M | -4.89M | -6.82M | -5.81M | -5.74M | -4.00M | -3.72M | -3.66M | -3.50M | -6.17M | -4.37M | -4.56M | -3.43M | -4.85M | -3.81M | -3.22M | -3.15M | -3.42M | -3.27M | -4.07M | -4.01M | -3.32M | -35.45M | -99.62M |
| Net Income | -8.52M | -1.56M | -3.76M | -2.48M | -2.55M | 1.79M | -2.43M | -3.83M | -3.08M | -2.99M | -5.68M | -5.68M | -12.94M | -1.17M | -17.83M | -4.52M | 1.32M | -186.00K | -5.59M | -4.76M | -3.36M | -3.48M | -3.36M | -5.98M | -4.69M | -4.35M | -3.81M | -1.03M | -2.49M | -1.65M | -3.66M | -2.52M | -1.61M | -3.69M | -3.84M | -9.83M | -352.77M | -99.80M |
| Diluted EPS | - | - | - | -0.04 | - | 0.03 | -0.04 | -0.05 | - | -0.04 | -0.32 | -0.31 | -0.67 | -0.08 | -0.78 | -0.19 | -0.06 | -0.01 | -0.22 | -5.38 | -2.90 | -2.70 | -1.65 | -2.58 | -2.01 | -1.15 | -0.97 | -2.90 | -4.42 | -2.92 | -5.49 | -3.08 | -485.30 | -744.35 | -382.29 | -79.73 | -32.89 | -1.30 |
| R&D Expense | - | 750.35K | 1.25M | 1.19M | 1.52M | 1.53K | 1.29M | 981.73K | 654.00K | 1.41M | 3.03M | 4.29M | 3.80M | 2.55M | 2.92M | 2.31M | 2.68M | 2.27M | 1.51M | 1.12M | 1.31M | 1.33M | 1.32M | 1.38M | 1.49M | 1.76M | 953.00K | 751.00K | 886.00K | 684.00K | 722.00K | 788.00K | 870.00K | 1.08M | 945.00K | 822.00K | 858.00K | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 478.00K | 1.50M | 661.00K | 493.00K | 778.00K | 605.00K | 520.00K | 548.00K |
| Gross Profit | - | - | - | - | - | 478.00K | 650.00K | 273.00K | 224.00K | 324.00K | 61.00K | -62.00K | 5.52M |
| Operating Income | -8.52M | -1.07M | -9.81M | -9.32M | -22.85M | -26.68M | -24.00M | -14.39M | -18.14M | -15.52M | -12.43M | -13.90M | -243.84M |
| Net Income | -8.52M | -1.07M | -9.84M | -6.88M | -28.02M | -28.62M | -9.78M | -14.13M | -18.13M | -14.07M | -8.85M | -11.74M | -40.89M |
| Diluted EPS | - | - | -0.17 | -0.12 | - | -1.26 | -12.99 | -11.80 | -7.38 | -52.13 | -14.56 | -3,282.26 | -1.85 |
| R&D Expense | 4.25M | 171.78K | 4.50M | 3.65M | 14.39M | 9.94M | 8.06M | 4.58M | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 315.97K | 1.22M | 4.04M | 3.45M | 6.81M | 27.83M | 10.35M | 6.55M | 14.10M | 17.29M | 7.69M | 3.54M | 303.93M |
| Total Equity | - | -7.85K | -267.98K | -1.56M | -15.00K | -3.44M | -7.49M | 9.85M | 5.83M | 3.87M | 11.26M | 8.15M | 2.35M | 1.06M | 300.91M |
| Cash & Equivalents | 0 | 217 | 15.97K | 418.89K | 2.64M | - | - | - | - | - | 11.01M | 14.55M | 5.18M | 1.09M | 7.28M |
| Total Liabilities | - | - | 583.95K | 2.78M | 4.06M | 6.89M | 14.30M | 17.97M | 4.51M | 2.68M | 2.85M | 9.14M | 5.34M | 2.48M | 3.02M |
| Current Liabilities | - | - | 583.95K | 1.20M | 2.33M | 6.89M | 14.30M | 17.97M | 3.80M | 2.42M | 2.65M | 1.99M | 1.88M | 2.16M | 3.02M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.01K | -348.70K | -6.32M | -7.94M | -19.32M | -19.62M | -21.00M | -11.74M | -13.39M | -14.31M | -10.42M | -11.04M | -16.51M |
| Investing Cash Flow | 0 | 0 | -378.00K | 378.00K | -190.00K | -440.00K | -769.00K | -9.00K | -56.00K | -11.00K | -29.00K | -5.00K | -426.53M |
| Financing Cash Flow | 12.23K | 364.45K | 7.48M | 9.69M | 22.22M | 40.03M | 1.65M | 9.64M | 21.13M | 17.87M | 1.08M | 6.95M | 449.24M |
| Capital Expenditure | - | - | - | - | -190.00K | -440.00K | -278.00K | -63.00K | -54.00K | -17.00K | -29.00K | -5.00K | - |
| Free Cash Flow | - | - | - | - | -19.52M | -20.06M | -21.28M | -11.80M | -13.44M | -14.33M | -10.45M | -11.05M | - |
Ratios (Annual)
Figures in %.
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | 100.0% | 43.4% | 41.3% | 45.4% | 41.6% | 10.1% | -11.9% | 1,006.8% |
| Operating Margin % | - | - | - | - | - | -5,580.5% | -1,604.0% | -2,176.4% | -3,679.9% | -1,994.3% | -2,054.2% | -2,673.7% | -44,496.4% |
| Net Margin % | - | - | - | - | - | -5,988.1% | -653.8% | -2,137.7% | -3,677.9% | -1,808.7% | -1,462.8% | -2,258.1% | -7,461.7% |
| ROE % | 108,507.6% | 398.3% | 629.5% | 45,878.7% | 374.2% | -290.5% | -167.6% | -365.0% | -161.1% | -172.6% | -376.6% | -1,108.8% | -13.6% |
| ROCE % | - | 398.3% | -52,895.7% | -545.0% | 305.1% | -270.7% | -366.6% | -348.9% | -158.5% | -101.4% | -213.8% | -1,008.2% | -81.0% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Pantera Capital Partners LP | 8.25% | 4.99M | $13.77M |
| 2 | Kathmere Capital Management, Llc | 7.60% | 4.59M | $12.68M |
| 3 | Arrington Capital Management, LLC | 1.09% | 658.91K | $1.82M |
| 4 | Blackrock Inc. | 1.05% | 632.92K | $1.75M |
| 5 | Vr Advisory Services Ltd | 0.96% | 581.31K | $1.60M |
| 6 | LPL Financial LLC | 0.93% | 560.43K | $1.55M |
| 7 | Vanguard Capital Management LLC | 0.92% | 555.98K | $1.53M |
| 8 | Geode Capital Management, LLC | 0.85% | 512.02K | $1.41M |
| 9 | Saba Capital Management, L.P. | 0.52% | 316.05K | $872.30K |
| 10 | Yorkville Advisors Global, LP | 0.50% | 300.00K | $828.00K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HSDT
Solana (NasdaqCM:HSDT) Stock Fair Value Moves Lower As Analysts Trim Growth Outlook - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOV2xfeXFaLUZncVFBQ1JMSktuQlEzRG1BbDFheVBvOTZjN0JjOGltc2RmZ2VBdmtJeVVuR3hYY0l3WXN5eTgtX2pVdXVmTlhmNGZ5b3pXMnluUDhVMDQ4NFhQbFBod190eUN3XzdvbTRJbmNKOEVrU0xFdG1VZzhscnlSLVJvbXpnZGJKZk…
Helius Medical Technologies Inc Class A (NASDAQ: HSDT) Stock Price, News & Analysis - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE5yM3FnQTF2Sy1aUk1WWXYwMWltcXllY3ZVQUZwU1NxWE0tX3BWZjgxQmc1WUN2LXJ4Y0hhc2JHZEUxeG9wY1BwRGYzRXp2MnRSYTJSdldB?oc=5" target="_blank">Helius Medical Technologies Inc Class A (NASDAQ: HS…
Solana Company reports $30.3M Q2 net loss with staking revenue - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQYmU5LUJtOGhkcWVTNHZ5M1RVWVlRVGVOSElIOURIb1Btcmc0cEdxZy14Y19XbTlISlRfVjI1c0RWYkVIbEVheVFGZzRUNlJzUUQyYzhESjJaMjZzaDh6dHlJVm1TTHVTN0pkQVVEbHBhLUpkTWkwVG5LcVdnenMwZ3MyaE5UUXJjR0c4di…
HSDT Forecast — Price Target — Prediction for 2027 - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBINzc4aEl6azZ6Y0V4eXZabzZkb1ZONS1nR0xyV2NHa0RxQXA5YkpBNUZaT0toRVRIa2NpaUhvVlQwdkRxOVlLbGlBOXg5bWg5LWNEVHVyU2NHVTJIWWRyZElCTnh2S051SHRwNXBkNmlDWEdzdzh4cG5n?oc=5" target="_blank">HSD…
HSDT - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE4xVzBkcXRYQ1ZPUmFsWEs0NXBlWC1kWmV0YTNYaWkxcVRGTWx1VDAyQlc1TUkzeGpKVkFRUHFJUFlyYWdObXc?oc=5" target="_blank">HSDT</a> <font color="#6f6f6f">Finviz</font>…
Forward Industries Proposes All-Stock Business Combination with Solana Company; HSDT Board Declines Offer - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQSE1LaHVBUzdoYnI5Qk56VlBCVnhLQkZrX0IzTWszYUFBUnZSRVlXbV9WbDBVNXVYUXhNMngxYlRXYldXWENTVTNKQmFyWFdLMnd4VFZtbGstMnowOW1OYlA0blJ5ZEJsN2hPeFFpUDhuaFM4NktqbWVWT3loekxqZkxsN1gwZGtfVjRrbG…
HSDT — Frequently Asked Questions
What is the current share price of Solana Company (HSDT)?
As of 2026-09-19 21:16 PDT, Solana Company (HSDT) trades at $2.24 on NasdaqCM. Its 52-week range is $1.27 to $24.13.
What is the market capitalisation of HSDT?
Solana Company (HSDT) has a market capitalisation of $135.43M on NasdaqCM.
What is the P/E ratio of HSDT?
HSDT trades at a trailing price-to-earnings (P/E) ratio of 0.01. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is 0.98.
Is HSDT a good stock to buy?
This page provides a data-driven analysis of Solana Company (HSDT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.